ProHealth Longevity launches pharmaceutical-grade methylene blue supplement

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

ProHealth Longevity has introduced a pharmaceutical-grade methylene blue dietary supplement aimed at enhancing mitochondrial function, cellular energy, and cognitive performance, according to the company. Each 15 mg capsule is precisely dosed and manufactured to stringent quality standards, including third-party testing and production in a GMP-certified, FDA-inspected facility, the company said that.

The supplement is designed for daily use, with the recommendation to take one capsule with water and food—typically earlier in the day to support focus—and can be incorporated into wellness routines involving NAD⁺ precursors, CoQ10, or antioxidants, according to the company. It is offered exclusively through the official ProHealth Longevity website, where customers also have access to multi-bottle bundles, subscription pricing, and a satisfaction policy, the company claims.

ProHealth Longevity positions this product as a more precise and safer alternative to liquid methylene blue formulations, noting that capsules eliminate risks of contamination, staining, or inaccurate dosing. The company claims that methylene blue’s mechanism—acting as an electron carrier in the mitochondrial electron transport chain—can enhance ATP production, reduce oxidative stress, and support brain health and mood by boosting neuronal energy metabolism.

While stating that most users tolerate the supplement well, ProHealth Longevity advises caution for individuals taking SSRIs or MAO inhibitors and notes possible mild side effects such as digestive discomfort or temporary urine discoloration. The company said that such effects are generally minor when the supplement is taken as directed.

Source: https://www.accessnewswire.com/newsroom/en/consumer-and-retail-products/prohealth-methylene-blue-review-2025-pharmaceutical-grade-mitochondria-1067204

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE